Health knowledge made personal
Join this community!
› Share page:
Go
Search posts:

A Unique Infectious Hepatitis C Virus Clone, Strain HC-TN (genotype 1a)

Posted Jul 13 2009 5:00pm

Description of Invention:
It is anticipated that this infectious clone of hepatitis C virus (HCV) strain HC-TN (genotype 1a) will be useful for the development of vaccines and antiviral drugs that target HCV, genotype 1a. The HC-TN strain is unique because it has been shown to cause fulminant hepatitis. To date, only one other HCV strain, JFH1 (genotype 1b), has been isolated that is known to cause fulminant hepatitis. Additionally, little is known about the etiology of fulminant hepatitis C disease. Therefore, the HC-TN strain may be useful as a tool for studying the etiology of fulminant hepatitis. This invention includes the infectious clone, nucleotide sequences of the clone, and polypeptides encoded by the HC-TN clone. Methods are included for producing attenuated HCV, and for screening therapeutics against HCV and developing vaccines and diagnostics.

Apparently, no companies or other laboratories have this HC-TN strain. The availability of the pHC-TN clone will be highly useful to pharmaceutical companies since no further research is required for its commercialization into, e.g., assays for testing antiviral compounds targeting HCV.

Applications:
  • Production of attenuated viruses and polypeptides
  • HCV vaccines, diagnostics, therapeutics and screening tool for anti-HCV compounds


Advantages:
There is no universally effective therapy against HCV infection. This invention enables development of vaccines, diagnostics and therapeutics that are specific for the HC-TN strain or HCV genotype 1a.

Development Status:
The technology is currently in the preclinical stage of development.

Inventors:
Jens Bukh (NIAID)
Robert H Purcell (NIAID)
Suzanne U Emerson (NIAID)
Akito Sakai (NIAID)
Patrizia Farci (NIAID)


Patent Status:
HHS, Reference No. E-249-2007/0
US, , Patent No. 7,678,569, Issued 16 Mar 2010
US, Application No. 12/637,696 filed 14 Dec 2009

No foreign rights available.

Relevant Publication:
  1. A Sakai et al. In vivo study of the HC-TN strain of hepatitis C virus recovered from a patient with fulminant hepatitis: RNA transcripts of a molecular clone (pHC-TN) are infectious in chimpanzees but not in Huh7.5 cells. J Virol. 2007 July;81(13):7208-7219. [ PubMed abs ]


Licensing Status:
Available for licensing.


Portfolios:
Infectious Diseases
Infectious Diseases - Diagnostics
Infectious Diseases - Therapeutics
Infectious Diseases - Vaccines



For Additional Information Please Contact:
Kevin Chang Ph.D.
NIH Office of Technology Transfer
6011 Executive Blvd. Suite 325,
Rockville, MD 20852
United States
Email: changke@mail.nih.gov
Phone: 301-435-5018
Fax: 301-402-0220


Ref No: 1989

Updated: 07/2009

Post a comment
Write a comment:

Related Searches